Non-Myeloablative Allogeneic Transplantation [electronic resource] /
Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.
Main Authors: | , , |
---|---|
Format: | Texto biblioteca |
Language: | eng |
Published: |
Boston, MA : Springer US : Imprint: Springer,
2002
|
Subjects: | Medicine., Oncology., Surgical transplantation., Medicine & Public Health., Transplant Surgery., |
Online Access: | http://dx.doi.org/10.1007/978-1-4615-0919-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
KOHA-OAI-TEST:206070 |
---|---|
record_format |
koha |
spelling |
KOHA-OAI-TEST:2060702018-07-30T23:35:25ZNon-Myeloablative Allogeneic Transplantation [electronic resource] / Bashey, Asad. editor. Ball, Edward D. editor. SpringerLink (Online service) textBoston, MA : Springer US : Imprint: Springer,2002.engNon-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.1 Development of allogeneic hematopoietic stem cell transplantation (HSCT) -- 2 Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in nonmyeloablative hematopoietic cell transplantation -- 3 Mobilization of allogeneic peripheral blood progenitor cells -- 4 Non-myeloblative induction of mixed hematopoietic chimerism: application to transplantation tolerance and hematologicmalignancies in experimental and clinical studies -- 5 Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer -- 6 Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice -- 7 Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy -- 8 Outpatient allografting in hematologic malignancies and nonmalignant disorders — applying lessons learned in the canine model to humans -- 9 Non-myeloablative transplants for congenital diseases.Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.Medicine.Oncology.Surgical transplantation.Medicine & Public Health.Oncology.Transplant Surgery.Springer eBookshttp://dx.doi.org/10.1007/978-1-4615-0919-6URN:ISBN:9781461509196 |
institution |
COLPOS |
collection |
Koha |
country |
México |
countrycode |
MX |
component |
Bibliográfico |
access |
En linea En linea |
databasecode |
cat-colpos |
tag |
biblioteca |
region |
America del Norte |
libraryname |
Departamento de documentación y biblioteca de COLPOS |
language |
eng |
topic |
Medicine. Oncology. Surgical transplantation. Medicine & Public Health. Oncology. Transplant Surgery. Medicine. Oncology. Surgical transplantation. Medicine & Public Health. Oncology. Transplant Surgery. |
spellingShingle |
Medicine. Oncology. Surgical transplantation. Medicine & Public Health. Oncology. Transplant Surgery. Medicine. Oncology. Surgical transplantation. Medicine & Public Health. Oncology. Transplant Surgery. Bashey, Asad. editor. Ball, Edward D. editor. SpringerLink (Online service) Non-Myeloablative Allogeneic Transplantation [electronic resource] / |
description |
Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use. |
format |
Texto |
topic_facet |
Medicine. Oncology. Surgical transplantation. Medicine & Public Health. Oncology. Transplant Surgery. |
author |
Bashey, Asad. editor. Ball, Edward D. editor. SpringerLink (Online service) |
author_facet |
Bashey, Asad. editor. Ball, Edward D. editor. SpringerLink (Online service) |
author_sort |
Bashey, Asad. editor. |
title |
Non-Myeloablative Allogeneic Transplantation [electronic resource] / |
title_short |
Non-Myeloablative Allogeneic Transplantation [electronic resource] / |
title_full |
Non-Myeloablative Allogeneic Transplantation [electronic resource] / |
title_fullStr |
Non-Myeloablative Allogeneic Transplantation [electronic resource] / |
title_full_unstemmed |
Non-Myeloablative Allogeneic Transplantation [electronic resource] / |
title_sort |
non-myeloablative allogeneic transplantation [electronic resource] / |
publisher |
Boston, MA : Springer US : Imprint: Springer, |
publishDate |
2002 |
url |
http://dx.doi.org/10.1007/978-1-4615-0919-6 |
work_keys_str_mv |
AT basheyasadeditor nonmyeloablativeallogeneictransplantationelectronicresource AT balledwarddeditor nonmyeloablativeallogeneictransplantationelectronicresource AT springerlinkonlineservice nonmyeloablativeallogeneictransplantationelectronicresource |
_version_ |
1756268198396690432 |